229 related articles for article (PubMed ID: 33616828)
21. Clinical characteristics, rapid identification, molecular epidemiology and antifungal susceptibilities of Talaromyces marneffei infections in Shenzhen, China.
Lau SKP; Xing F; Tsang CC; Tang JYM; Tan YP; Ye H; Lau RWT; Chen JHK; Lo SKF; Woo PCY
Mycoses; 2019 May; 62(5):450-457. PubMed ID: 30597630
[TBL] [Abstract][Full Text] [Related]
22. Voriconazole as therapy for systemic Penicillium marneffei infections in AIDS patients.
Supparatpinyo K; Schlamm HT
Am J Trop Med Hyg; 2007 Aug; 77(2):350-3. PubMed ID: 17690411
[TBL] [Abstract][Full Text] [Related]
23. Metagenomic next-generation sequencing for the early diagnosis of talaromycosis in HIV-uninfected patients: five cases report.
Chen Q; Qiu Y; Zeng W; Wei X; Zhang J
BMC Infect Dis; 2021 Aug; 21(1):865. PubMed ID: 34425764
[TBL] [Abstract][Full Text] [Related]
24. Talaromycosis in a renal transplant recipient returning from South China.
Vergidis P; Rao A; Moore CB; Rautemaa-Richardson R; Sweeney LC; Morton M; Johnson EM; Borman AM; Richardson MD; Augustine T
Transpl Infect Dis; 2021 Feb; 23(1):e13447. PubMed ID: 32794335
[TBL] [Abstract][Full Text] [Related]
25. Case Report: Bilateral Granulomatous Anterior Uveitis in HIV-patient with Disseminated
Khieu C; Apivatthakakul A; Kunavisarut P; Pathanapitoon K
Ocul Immunol Inflamm; 2020 Oct; 28(7):1066-1068. PubMed ID: 31577460
[TBL] [Abstract][Full Text] [Related]
26. Talaromycosis (Penicilliosis) Due to Talaromyces (Penicillium) marneffei: Insights into the Clinical Trends of a Major Fungal Disease 60 Years After the Discovery of the Pathogen.
Cao C; Xi L; Chaturvedi V
Mycopathologia; 2019 Dec; 184(6):709-720. PubMed ID: 31811603
[TBL] [Abstract][Full Text] [Related]
27. Amphotericin B and itraconazole for treatment of disseminated Penicillium marneffei infection in human immunodeficiency virus-infected patients.
Sirisanthana T; Supparatpinyo K; Perriens J; Nelson KE
Clin Infect Dis; 1998 May; 26(5):1107-10. PubMed ID: 9597237
[TBL] [Abstract][Full Text] [Related]
28. Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency Syndrome.
Chen X; Ou X; Wang H; Li L; Guo P; Chen X; Cai W; Tang X; Li L
Mycopathologia; 2022 Jun; 187(2-3):205-215. PubMed ID: 35237935
[TBL] [Abstract][Full Text] [Related]
29. Clinical features of patients with talaromycosis marneffei and microbiological characteristics of the causative strains.
Peng L; Shi YB; Zheng L; Hu LQ; Weng XB
J Clin Lab Anal; 2022 Nov; 36(11):e24737. PubMed ID: 36268985
[TBL] [Abstract][Full Text] [Related]
30. Amphotericin B in neonates: deoxycholate or lipid formulation as first-line therapy - is there a 'right' choice?
Turkova A; Roilides E; Sharland M
Curr Opin Infect Dis; 2011 Apr; 24(2):163-71. PubMed ID: 21301335
[TBL] [Abstract][Full Text] [Related]
31. Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.
Patterson TF; Boucher HW; Herbrecht R; Denning DW; Lortholary O; Ribaud P; Rubin RH; Wingard JR; DePauw B; Schlamm HT; Troke P; Bennett JE; ;
Clin Infect Dis; 2005 Nov; 41(10):1448-52. PubMed ID: 16231256
[TBL] [Abstract][Full Text] [Related]
32. Case report: Diagnosis of
Du R; Feng Y; Mao H
Front Cell Infect Microbiol; 2023; 13():1163846. PubMed ID: 37469600
[TBL] [Abstract][Full Text] [Related]
33. Disseminated Talaromyces marneffei infection presenting as multiple intestinal perforations and diffuse hepatic granulomatous inflammation in an infant with STAT3 mutation: a case report.
Pan M; Qiu Y; Zeng W; Tang S; Wei X; Zhang J
BMC Infect Dis; 2020 Jun; 20(1):394. PubMed ID: 32493232
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of Talaromyces marneffei infection in a kidney transplant recipient with voriconazole followed by itraconazole for the first time.
Li Y; Tang M; Sun S; Hu Q; Deng S
J Mycol Med; 2022 Mar; 32(1):101214. PubMed ID: 34763148
[TBL] [Abstract][Full Text] [Related]
35. [Diagnosis and management of fungal infections and pneumocystis pneumonitis in pediatric cancer patients].
Groll AH; Ritter J
Klin Padiatr; 2005 Nov; 217 Suppl 1():S37-66. PubMed ID: 16288352
[TBL] [Abstract][Full Text] [Related]
36. Machine learning-based in-hospital mortality prediction of HIV/AIDS patients with Talaromyces marneffei infection in Guangxi, China.
Shi M; Lin J; Wei W; Qin Y; Meng S; Chen X; Li Y; Chen R; Yuan Z; Qin Y; Huang J; Liang B; Liao Y; Ye L; Liang H; Xie Z; Jiang J
PLoS Negl Trop Dis; 2022 May; 16(5):e0010388. PubMed ID: 35507586
[TBL] [Abstract][Full Text] [Related]
37. Talaromycosis marneffei of the Cervical Spine: An Unusual Infection.
Bunmaprasert T; Munpinit M; Sugandhavesa N; Liawrungrueang W
J Am Acad Orthop Surg Glob Res Rev; 2021 Jun; 5(6):. PubMed ID: 34106903
[TBL] [Abstract][Full Text] [Related]
38. MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of
Fang L; Liu M; Huang C; Ma X; Zheng Y; Wu W; Guo J; Huang J; Xu H
Infect Drug Resist; 2022; 15():3449-3457. PubMed ID: 35800121
[TBL] [Abstract][Full Text] [Related]
39. Talaromyces marneffei infection and complicate manifestation of respiratory system in HIV-negative children.
Yang Q; Wu Y; Li X; Bao Y; Wang W; Zheng Y
BMC Pulm Med; 2023 Mar; 23(1):100. PubMed ID: 36978020
[TBL] [Abstract][Full Text] [Related]
40. Voriconazole versus amphotericin B in cancer patients with neutropenia.
Jørgensen KJ; Gøtzsche PC; Johansen HK
Cochrane Database Syst Rev; 2006 Jan; (1):CD004707. PubMed ID: 16437492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
